David Gionco
2017
In 2017, David Gionco earned a total compensation of $1.1M as Vice President of Finance and Chief Accounting Officer at Stemline Therapeutics, a 24% decrease compared to previous year.
Compensation breakdown
| Bonus | $167,694 |
|---|---|
| Non-Equity Incentive Plan | $19,298 |
| Salary | $304,897 |
| Stock Awards | $618,631 |
| Total | $1,110,520 |
Gionco received $618.6K in stock awards, accounting for 56% of the total pay in 2017.
Gionco also received $167.7K in bonus, $19.3K in non-equity incentive plan and $304.9K in salary.
Rankings
In 2017, David Gionco's compensation ranked 8,495th out of 14,666 executives tracked by ExecPay. In other words, Gionco earned more than 42.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,495 out of 14,666 | 42nd |
Division Manufacturing | 3,221 out of 5,772 | 44th |
Major group Chemicals And Allied Products | 1,072 out of 2,075 | 48th |
Industry group Drugs | 847 out of 1,731 | 51st |
Industry Pharmaceutical Preparations | 661 out of 1,333 | 50th |
Source: SEC filing on April 30, 2018.
Gionco's colleagues
We found two more compensation records of executives who worked with David Gionco at Stemline Therapeutics in 2017.